Orthocell Limited (OCC) specialises in regenerative medicine, dedicated to enhancing mobility for patients through innovative products designed to repair a range of bone and soft tissue injuries. At the core of Orthocell's offerings is the CelGro platform, a series of collagen-based medical devices engineered to facilitate tissue reconstruction and promote healing across diverse applications in dental and orthopedic reconstructive procedures. Their focus on regenerative solutions underscores their commitment to advancing patient care and improving outcomes in medical interventions.